HHS Secretary Becerra orders Medicare to reassess premium hike on new Alzheimer’s drug

U.S. health secretary Xavier Becerra on Monday ordered Medicare to reassess a big premium increase facing millions of seniors this year, attributed in large part to a pricey new Alzheimer’s drug with questionable benefits. 

Becerra’s directive came days after drugmaker Biogen slashed the price of its $56,000-a-year medication, Aduhelm, to $28,200 a year — a cut of about half. 

“With the 50% price drop of Aduhelm on Jan. 1, there is a compelling basis … to reexamine the previous…

Read the Full Article Here foxnews

Written by Bourbiza Mohamed

A technology enthusiast and a passionate writer in the field of information technology, cyber security, and blockchain

China’s Covid Outbreak Complicates Safety Plan for Beijing Olympics

Aakash Chopra on whether Shardul Thakur’s performance means the end of the road for Hardik Pandya in Tests